Drug Trial Radar · NCT07488897
RIG 101 Trial in Healthy Adults and Adults With Asthma
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
82
Planned (sponsor's estimate)
Start
Feb 9, 2026
Primary completion
Feb 2027
Study completion Feb 2027
Sponsor
- Lead sponsor
- RIGImmune Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Virtus Respiratory Research; Medicines Evaluation Unit Ltd
- First posted
- Mar 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Nested Phase 1-2 Trial of RIG-101 in Healthy and Asthmatic Participants Assessing Safety, Tolerability and Viral Challenge Efficacy
Conditions
- Healthy Adult Participants
- Asthma Exacerbation
- Safety and Efficacy
Interventions
RIG-101Drug
Single, and repeat escalating intranasal administrations of RIG-101
PlaceboOther
Single and repeat Intranasal administrations
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Day 1-35
- Systolic/Diastolic blood pressureTime frame: Day 0 - 35
- Physical examinationsTime frame: Day 0 -35
- Nasal examinationsTime frame: Day 0 - 35
- Spirometry (FEV₁ and FVC)Time frame: Day 0-35
- Triplicate 12-lead ECGs and single 12-lead ECGsTime frame: Day 0 - 35
- Safety laboratory testing-haematologyTime frame: Day 0 - 35
- Safety laboratory testing-Serum ChemistryTime frame: Day 0- 35
- Safety laboratory testing-CoagulationTime frame: Day 0 -35
- Lower respiratory tract symptom score assessmentsTime frame: Day -7 to 35
- AUC of Lower respiratory tract symptom scoreTime frame: Day -7 to 35
- Vital Signs - heart rateTime frame: Day 0 - 35
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Virtus Respiratory Research Ltd
London, United Kingdom · Recruiting
Medicines Evaluation Unit
Manchester, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.